Australia markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.9500+0.0800 (+4.28%)
At close: 04:00PM EDT
1.9300 -0.02 (-1.03%)
After hours: 06:22PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
116,334
116,334
75,475
78,447
227,547
Cost of revenue
43,267
43,267
26,967
14,217
2,392
Gross profit
73,067
73,067
48,508
64,230
225,155
Operating expenses
Research development
86,107
86,107
118,927
105,975
146,936
Selling general and administrative
142,523
142,523
109,082
184,985
199,615
Total operating expenses
228,630
228,630
228,009
290,960
346,551
Operating income or loss
-155,563
-155,563
-179,501
-226,730
-121,396
Interest expense
58,976
58,976
56,810
46,353
22,670
Total other income/expenses net
5,291
5,291
2,652
3,975
515
Income before tax
-209,248
-209,248
-233,659
-269,108
-143,551
Income from continuing operations
-209,248
-209,248
-233,659
-269,108
-143,551
Net income
-209,248
-209,248
-233,659
-269,108
-143,551
Net income available to common shareholders
-209,248
-209,248
-233,659
-269,108
-143,551
Basic EPS
-9.31
-2.03
-3.52
-9.31
-5.23
Diluted EPS
-9.31
-2.03
-3.52
-9.31
-5.23
Basic average shares
28,903
103,107
66,407
28,903
27,474
Diluted average shares
28,903
103,107
66,407
28,903
27,474